The NYSDOH AIDS Institute’s Office of Drug User Health presents a one-day conference for multidisciplinary professionals, advocates, and clinicians (MDs/DOs/NPs/PAs), who interface with, deliver services to, or provide care for women of childbearing age in New York State. The conference will feature a keynote address by renowned physician and researcher, Dr. Mishka Terplan, on "Opioid Use Disorder: Caring for the Pregnant Patient, A Life Course Perspective". The conference will also include a dialogue session with an expert panel about drug user health in NYS. There will be opportunities to network and collaborate with other attendees in the afternoon as the group considers how to overcome the presented challenges and recommend systemic improvements to increase access to and quality of health care for women who use drugs in NYS.
Authorized practitioners (MDs, DOs, NPs & PAs) can choose to participate in a free buprenorphine waiver eligibility training in the afternoon (Session 3) which will specifically inform those in OB/GYN practice settings. Under current regulations, authorized practitioners are required to obtain a ‘waiver’ to prescribe buprenorphine. Please contact us for further information.
Agenda:
Morning Session (open to everyone)
Session 1
10:00-10:30AM, Opening & Welcoming Remarks, Johanne Morne
10:30-11:30AM, Keynote Presentation: Dr. Mishka Terplan, “Opioid Use Disorder: Caring for the Pregnant Patient, A Life Course Perspective”
11:30AM-1:00PM, Drug User Health Panel: Dr. Sharon Stancliff, Moderator, “From the Frontline: Women Who Use Drugs in NYS”
Afternoon Breakout Sessions (pick one only)
Session 2
1:00-3:30PM, “Statewide Coordinated Response Think Tank”
Session 3*
1:00-5:30PM, Dr. Bruce Trigg: “Buprenorphine Waiver Eligibility Training” (*CMEs available)
Location:
Where: Hilton Garden Inn Troy 235 Hoosick St. Troy, NY 12180
Directions: https://goo.gl/vQaYnt
Details on the buprenorphine waiver training:
The NYSDOH, AIDS Institute is sponsoring a Free Buprenorphine Waiver Training for obstetricians and gynecologists. Physicians, Physician Assistants, Pharmacists and Medical Residents are also welcome and highly encouraged to attend this training. In response to opioid overdose deaths in New York State, increased access to buprenorphine treatment for opioid overdose disorder is urgently needed, and OB/GYNs are paving the way to ensure women of childbearing age obtain access to this highly effective treatment.
Under current regulations, authorized practitioners (MDs, DOs, NPs & PAs) are required to obtain a ‘waiver’ to prescribe buprenorphine. To acquire this waiver, physicians are required to complete a standardized buprenorphine waiver 8-hour training. Nurse Practitioners (NPs) and Physician Assistants (PAs) are required to complete the standardized buprenorphine waiver 8-hour training as well as an additional 16 hours of online training as established by CARA. The buprenorphine waiver 8-hour training is offered in a half-and-half format [3.5 hours of online training completed after 4.5 hours of the live training]. Upon completion of the required training, providers will meet the requirement of the DATA 2000 to apply for a waiver to prescribe buprenorphine for opioid-dependent patients. Please contact us for further information.
CME CREDITS: The School of Public Health, University at Albany is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians. The School of Public Health, University at Albany designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Trainer: Bruce Trigg, MD, Harm Reduction Coalition, New York,
ACCREDITATION: This activity has been planned and implemented by NYSDOH, AIDS Institute in accordance with the accreditation requirements and policies of the American Academy of Addiction Psychiatry (AAAP) and in partnership with the Nurse Practitioners Association (NSA) of NY State and Harm Reduction Coalition.
Funding for this course was made possible (in part) by 1U79TI026556 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. American Academy of Addiction Psychiatry is the sponsoring data organization.
For any questions please contact:
Erin Bortel, AIDS Institute, Office of Drug User Health at erin.bortel@health.ny.gov or Lyla Hunt, AIDS Institute, Office of Drug User Health at lyla.hunt@health.ny.gov
